Detalhe da pesquisa
1.
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.
Lancet Oncol
; 23(6): 758-767, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588752
2.
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
Cancer
; 127(8): 1311-1317, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296083
3.
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 21(11): 1433-1442, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035457
4.
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Lancet Oncol
; 21(11): 1423-1432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035459
5.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med
; 375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717299
6.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 19(8): 1117-1125, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026000
7.
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study.
Clin Lymphoma Myeloma Leuk
; 22(7): 504-512, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151584
8.
Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial.
Anesthesiology
; 109(2): 289-96, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18648238
9.
The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer.
Cancer Chemother Pharmacol
; 81(3): 497-503, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29322231
10.
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
Clin Pharmacol Drug Dev
; 7(5): 532-542, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346833
11.
Predictors and consequences of multiple persistent postmastectomy pains.
J Pain Symptom Manage
; 34(6): 619-27, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17629668
12.
Local administration of norepinephrine in the stump evokes dose-dependent pain in amputees.
Clin J Pain
; 22(5): 482-6, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16772803
13.
A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
Clin Cancer Res
; 20(10): 2793-804, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634378
14.
Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.
Clin Cancer Res
; 18(4): 1092-100, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22179664
15.
A web-based cross-sectional epidemiological survey of complex regional pain syndrome.
Reg Anesth Pain Med
; 34(2): 110-5, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19282709
16.
Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states.
Pain Med
; 8(7): 554-62, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17883740
17.
Episiotomy versus fetal manipulation in managing severe shoulder dystocia: a comparison of outcomes.
Am J Obstet Gynecol
; 191(3): 911-6, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15467564